Growth Metrics

Ptc Therapeutics (PTCT) Amortization - Intangibles (2017 - 2025)

Historic Amortization - Intangibles for Ptc Therapeutics (PTCT) over the last 9 years, with Q3 2025 value amounting to $7.5 million.

  • Ptc Therapeutics' Amortization - Intangibles rose 14815.55% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 8610.75%. This contributed to the annual value of $60.7 million for FY2024, which is 7271.86% down from last year.
  • Per Ptc Therapeutics' latest filing, its Amortization - Intangibles stood at $7.5 million for Q3 2025, which was up 14815.55% from $4.1 million recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Amortization - Intangibles peaked at $77.2 million during Q4 2023, and registered a low of $2.9 million during Q2 2024.
  • For the 5-year period, Ptc Therapeutics' Amortization - Intangibles averaged around $24.8 million, with its median value being $16.4 million (2021).
  • As far as peak fluctuations go, Ptc Therapeutics' Amortization - Intangibles tumbled by 9571.49% in 2024, and later soared by 14815.55% in 2025.
  • Ptc Therapeutics' Amortization - Intangibles (Quarter) stood at $16.4 million in 2021, then soared by 118.5% to $35.8 million in 2022, then skyrocketed by 115.51% to $77.2 million in 2023, then tumbled by 95.71% to $3.3 million in 2024, then skyrocketed by 127.82% to $7.5 million in 2025.
  • Its last three reported values are $7.5 million in Q3 2025, $4.1 million for Q2 2025, and $3.8 million during Q1 2025.